Pharmaceutical

Seres Therapeutics gets grant for composition of isolated bacteria in capsule for dysbiosis treatment

Discover the groundbreaking patent by Seres Therapeutics Inc for a unique composition targeting dysbiosis in mammals. Learn how specific bacterial species in a capsule can inhibit pathogenic bacteria growth.

Apr 25, 2024 - 00:00
Discover the groundbreaking patent by Seres Therapeutics Inc for a unique composition targeting dysbiosis in mammals. Learn how specific bacterial species in a capsule can inhibit pathogenic bacteria growth.
Read the original article

Tags:

Previous Article

Ipsen gets grant for treatment of diseases with specific benzothiazepine and ben...

Next Article

Findings of large-scale study on 572 Asian families supports gene-directed manag...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A letter from the executive editor: STAT’s investigation into a UnitedHealth algorithm

A letter from the executive editor: STAT’s investigatio...

Nov 15, 2023

Grit Biotechnology secures funds for development of pipeline programmes

Grit Biotechnology secures funds for development of pip...

Sep 11, 2023

Health Canada approves AstraZeneca-Merck’s prostate cancer therapy

Health Canada approves AstraZeneca-Merck’s prostate can...

Jul 15, 2023